RECRUITINGOBSERVATIONAL
Chinese PD-LRRK2 Registry
The Chinese Parkinson's Disease With LRRK2 Variants Registry
About This Trial
The purpose of the Chinese PD-LRRK2 Registry(CPD-LRRK2R) is to develop a database of patients of Parkinson's disease with leucine-rich repeat kinase 2 (LRRK2) gene variants in mainland China.
Who May Be Eligible (Plain English)
Who May Qualify:
- Patients diagnosed with PD by the United Kingdom Parkinson's Disease Society Brain Bank clinical diagnostic criteria or other standard criteria; PD patients detected with positive LRRK2 variants
Who Should NOT Join This Trial:
\-
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Patients diagnosed with PD by the United Kingdom Parkinson's Disease Society Brain Bank clinical diagnostic criteria or other standard criteria; PD patients detected with positive LRRK2 variants
Exclusion Criteria:
\-
Locations (1)
Xiangya Hospital of Central South University
Changsha, Hunan, China